Health Absorbed | Biological Age Assessment

How Old Is Your Body Really?

A complete, evidence-based framework for measuring biological age — from accessible clinical tests to advanced epigenetic and glycan biomarkers — with interpretation and intervention guidance grounded in peer-reviewed science.

16 HallmarksAssessment Coverage
3 TiersUniversal to Advanced
GlycanAgeIgG Glycan Biomarker
A–D GradeEvidence Quality
74 Years OldLiving the Framework
explore
Why Assessment Matters

Chronological age tells you how many years you have lived. Biological age tells you how fast your body has aged relative to those years — and unlike chronological age, biological age is measurable, modifiable, and directly responsive to the exercise, dietary, and lifestyle interventions described across the Health Absorbed science framework.

Two people both aged 65 may have biological ages of 52 and 78 respectively. The difference is not genetic fate — it is the cumulative biological consequence of decades of lifestyle decisions. Every test described in this framework is a window into one or more of the sixteen hallmarks of aging, providing both a baseline measure and a monitoring tool for tracking the impact of intervention over time.

The assessment framework is organised across three tiers: Tier 1 tests are universally accessible and appropriate for all adults; Tier 2 tests are targeted to individuals with specific risk profiles or those seeking deeper biological age characterisation; Tier 3 tests represent the current frontier of precision longevity medicine, available commercially but at higher cost and complexity.

The Author's Personal Baseline

At age 74, training five days per week, following a ketogenic diet and 16:8 intermittent fasting, the author of this framework maintains a VO₂max, grip strength, resting heart rate, blood pressure, and HRV profile consistent with a biological age substantially below chronological age — a living demonstration that the biomarkers described here are genuinely responsive to the interventions discussed. Assessment without intervention is data collection. Intervention without assessment is guesswork. The two together constitute evidence-based longevity practice.

Tier 1
Universal Assessment Panel
Accessible, low-cost tests appropriate for all adults — the foundation of any biological age evaluation
VO₂
MAX
Maximal Oxygen Uptake (VO₂max)
Cardiorespiratory Fitness — Gold Standard Longevity Biomarker
The single most powerful independent predictor of all-cause mortality. Each 1-MET increment in VO₂max is associated with approximately 13% reduction in mortality risk. Reflects mitochondrial capacity, cardiac function, and oxygen delivery — simultaneously assessing Hallmarks 7, 8, and 12.[1,2]
HallmarksH7, H8, H12
EvidenceGrade A
AccessibilitySubmaximal estimate: high
Measurement
Direct: incremental CPET on treadmill or cycle ergometer with expired gas analysis (criterion standard). Estimated: Chester Step Test, Rockport Walk Test, YMCA Cycle Test, or resting non-exercise equations (accuracy ±10–15% vs direct measurement).
Normative values — Men
Age 60–69: Poor <18, Fair 18–22, Good 23–30, Excellent 31–40, Superior >40 mL/kg/min. Age 70+: Poor <15, Fair 15–20, Good 21–27, Excellent 28–35, Superior >35 mL/kg/min. Each 3.5 mL/kg/min increment = 1 MET = 13% mortality reduction.
Hallmark connection
VO₂max decline of ~10% per decade after age 30 directly tracks mitochondrial deterioration (H8), nutrient sensing dysregulation (H7), and altered intercellular communication via declining GH/IGF-1 (H12). HIIT is the most potent stimulus for VO₂max improvement at any age.
Intervention targets
A 70-year-old who exercises regularly can maintain a VO₂max equivalent to a sedentary 30-year-old. The Norwegian 4×4 protocol (4 minutes at 85–95% HRmax × 4 sets, 3 sessions/week) produces the largest VO₂max improvements in clinical populations.
HRV
Heart Rate Variability (HRV)
Autonomic Nervous System Health — Allostatic Load Index
Quantifies the temporal variation between successive heartbeats, reflecting autonomic balance. RMSSD is the gold-standard vagal index. Higher HRV indicates lower allostatic load, better recovery capacity, and superior cardiovascular health. Directly measures Hallmark 10 (cellular allostatic load) and reflects H8 and H13.[3,4]
HallmarksH10, H8, H13
EvidenceGrade A
AccessibilityVery high — wearable devices
Measurement
Five-minute resting ECG or validated wearable (Polar H10, Garmin, Oura Ring, Whoop). Morning measurement before rising provides the most reliable and consistent daily tracking value. RMSSD is the primary metric; log-transformed values (lnRMSSD) are preferred for statistical analysis.
Interpretation
HRV is highly individual — reference your own baseline rather than population norms. A sustained decline of >20% below personal baseline indicates elevated physiological stress. RMSSD above 40ms in adults over 60 is generally associated with good cardiovascular health; below 20ms indicates poor autonomic regulation.
Hallmark connection
HRV declines at approximately 1–2% per year after age 40 due to progressive sympathetic dominance (H10 — allostatic load accumulation). Regular aerobic exercise, adequate sleep, and stress reduction substantially attenuate this decline and can reverse it in previously sedentary individuals.
HRV-guided training
HRV-guided training — adjusting daily training intensity based on morning HRV — has demonstrated superior VO₂max development compared to fixed prescription in RCTs. On high-HRV days, train at planned intensity. On low-HRV days (>10% below baseline), reduce intensity or substitute recovery activity.
BP
Blood Pressure and Pulse Wave Velocity
Vascular Age — ECM Stiffening Index
Resting blood pressure provides cardiovascular risk stratification. Pulse wave velocity (PWV) — the speed of the arterial pressure wave — is the gold-standard non-invasive measure of arterial stiffness, directly quantifying Hallmark 15 (ECM changes). PWV >10 m/s in adults over 50 indicates elevated cardiovascular risk.[5,6]
HallmarksH15, H13, H7
EvidenceGrade A
AccessibilityBP: very high; PWV: moderate
BP Classification (ESH 2018)
Optimal: <120/80 mmHg. Normal: 120–129/80–84. High normal: 130–139/85–89. Grade 1 hypertension: 140–159/90–99. Grade 2: 160–179/100–109. Grade 3: ≥180/110 mmHg. An exaggerated systolic BP response during exercise (>210 mmHg men, >190 mmHg women) independently predicts future hypertension.
Isometric protocol for BP reduction
Four sets of two-minute wall squats at 20–30% MVC, three times per week, produces systolic BP reductions of 10.9 mmHg — the most effective single exercise protocol for blood pressure reduction. Mechanism: chronic reduction in peripheral vascular resistance via improved endothelial nitric oxide bioavailability.
PWV measurement
Carotid-femoral PWV by applanation tonometry or oscillometric devices. Normal: <10 m/s adults <50 years; <12 m/s adults 50–70; reference values above 10 m/s at any age over 50 indicate elevated risk. PWV increases approximately 0.1 m/s per year from age 20 onward.
Hallmark connection
AGE crosslinks in arterial collagen and elastin (H15) are the primary structural determinant of arterial stiffness and the dominant driver of isolated systolic hypertension in older adults. Glycaemic control reduces new AGE formation; exercise reduces PWV through eNOS-mediated vascular remodelling.
GRIP
Grip Strength Dynamometry
Musculoskeletal Reserve — Stem Cell Exhaustion Proxy
Handgrip strength is a remarkably powerful surrogate of overall physiological reserve, independently predicting all-cause mortality, cardiovascular disease, cognitive decline, and hospitalisation in large prospective cohorts. Below 27 kg (men) and 16 kg (women) meets the EWGSOP2 diagnostic threshold for sarcopaenia.[7,8]
HallmarksH11, H9, H8
EvidenceGrade A
AccessibilityHigh — hydraulic dynamometer
Measurement protocol
Validated hydraulic dynamometer (Jamar preferred). Participant seated, shoulder adducted, elbow flexed to 90°, forearm neutral. Three maximal efforts per hand with 60-second rest between attempts. Record mean of three attempts per hand. Dominant hand norms: men 70–74 years approximately 32–35 kg; women 70–74 years approximately 19–22 kg.
Clinical thresholds
EWGSOP2 sarcopaenia: <27 kg men, <16 kg women. Low-normal (increased risk): men 27–32 kg, women 16–20 kg. Each 5 kg decrement in grip strength is associated with a 17% increase in cardiovascular mortality risk. Grip strength declines approximately 1–2% per year after age 50 without intervention.
Hallmark connection
Grip strength reflects the integrated output of H11 (stem cell exhaustion — satellite cell number and function), H8 (mitochondrial function — ATP availability for contraction), H9 (senescent cell burden in muscle), and H7 (nutrient sensing — anabolic signalling). A single test that captures four major hallmarks simultaneously.
Intervention
Progressive resistance training is the primary intervention. Even 8–12 weeks of appropriately dosed resistance training produces clinically significant grip strength improvements in septuagenarians and octogenarians. Protein intake ≥1.6 g/kg/day is essential for maximising the adaptive response to resistance training in older adults.
META
Fasting Metabolic and Inflammatory Panel
Nutrient Sensing Dysregulation and Inflammaging Quantification
A standard blood panel encompassing fasting glucose, insulin, HbA1c, hsCRP, IL-6, lipid profile, and vitamin D simultaneously assesses Hallmarks 7 (nutrient sensing), 13 (inflammaging), and 14 (dysbiosis via LPS-binding protein). hsCRP is the most widely available and accessible inflammaging biomarker in routine clinical use.[9,10]
HallmarksH7, H13, H14
EvidenceGrade A
AccessibilityVery high — standard clinical lab
Target values for longevity
Fasting insulin: <10 μIU/mL (optimal <6). HbA1c: <5.7%. HOMA-IR: <1.5. hsCRP: <1.0 mg/L. IL-6: <2 pg/mL. Total cholesterol/HDL ratio: <3.5. Triglycerides: <1.0 mmol/L. Vitamin D (25-OH-D): 75–150 nmol/L. GDF15: <1,200 pg/mL (emerging longevity biomarker).
Inflammaging indices
The Leiden Longevity Study demonstrated that individuals in the lowest quartile of IL-6 and CRP in their 70s had 4–6 years longer expected lifespans than those in the highest quartile — establishing inflammaging biomarkers as causal drivers of mortality rather than merely markers. Combined inflammatory indices (incorporating hsCRP, IL-6, and fibrinogen) are more predictive than any single marker alone.
Ketogenic diet effects
A ketogenic dietary pattern substantially reduces fasting insulin, HOMA-IR, triglycerides, and inflammatory markers compared with a high-carbohydrate diet in most metabolic phenotypes. The 16:8 intermittent fasting protocol additionally activates AMPK and SIRT1, further reducing nutrient sensing dysregulation (H7) and enabling the autophagy induction that attenuates H6 (disabled macroautophagy).
Exercise effects
A single bout of moderate exercise transiently elevates IL-6 (via myokine release from working muscle), followed by a more prolonged anti-inflammatory cascade. Chronically, regular exercise reduces hsCRP by approximately 0.4–0.8 mg/L and IL-6 by 10–15% — effects comparable to low-dose statin therapy for inflammatory risk reduction.
FUNC
Functional Performance Battery
Physical Function — Integrated Biological Age Proxy
The Short Physical Performance Battery (SPPB) assesses balance, gait speed, and chair stand performance — scoring 0–12. A score below 9 identifies elevated risk of disability, hospitalisation, and mortality. The 4-metre gait speed test alone is sometimes described as the "sixth vital sign" due to its predictive power for survival.[11]
HallmarksH11, H9, H10
EvidenceGrade A
AccessibilityVery high — no equipment
SPPB Components
Balance: tandem stand (feet in line), semi-tandem, side-by-side — 10 seconds each. Gait speed: time to walk 4 metres at usual pace (twice). Chair stands: five full sit-to-stand cycles without using arms. Each component scored 0–4; total 0–12. Above 10: good function. 7–9: moderate limitation. Below 7: substantial functional impairment.
Gait speed norms
Usual gait speed >1.0 m/s in adults over 65 is associated with excellent survival outcomes. Speed below 0.8 m/s indicates high risk. Speed below 0.6 m/s in adults over 70 is a clinical indicator of severe frailty requiring urgent intervention. Each 0.1 m/s improvement in gait speed is associated with a 12% reduction in mortality risk.
30-second Chair Stand
Number of full sit-to-stand cycles in 30 seconds from a standard chair without using arms. Men aged 70–74: below 12 indicates poor lower body strength. Women aged 70–74: below 11 indicates poor function. This single test captures lower body strength, power, neuromuscular coordination, and balance simultaneously.
Intervention
Resistance training targeting quadriceps, glutes, and posterior chain is the primary functional performance intervention. Balance training (single-leg standing, Bosu, proprioceptive challenges) is an essential complement for fall prevention. Functional improvement is achievable even in advanced frailty — the LIFE study demonstrated significant gait speed improvements in adults aged 70–89 with mobility limitation following a structured exercise programme.
Featured Biomarker
🧪

GlycanAge — The Inflammaging Biomarker

Measuring the N-glycans on your IgG antibodies to directly quantify the inflammatory dimension of biological aging — the most modifiable arm of the ageing process

GlycanAge is built on a fundamentally different scientific principle from epigenetic clocks or telomere length. Rather than reading DNA or measuring chromosome caps, it analyses the pattern of N-glycans — complex sugar molecules that are enzymatically attached to immunoglobulin G (IgG) antibodies at a single conserved site on the Fc domain. The composition of these glycans directly determines whether your IgG antibodies promote inflammation or suppress it — making GlycanAge the only commercially available biological age test that measures the inflammatory potential of the immune system itself.[36,37]

58%
Of age variance explained by three IgG glycans — vs 15–25% for telomere length
7.4
Years lower GlycanAge in regularly active vs inactive adults
30+
Years of peer-reviewed glycoscience research underpinning the test
350+
Peer-reviewed publications in the evidence base

How It Works

A finger-prick blood sample is posted to the laboratory. IgG is isolated and N-glycan composition is profiled by high-performance liquid chromatography. The resulting glycan pattern is compared against age-stratified population data to generate a GlycanAge score — the age at which your glycan profile would be average. A GlycanAge lower than your chronological age indicates an anti-inflammatory profile consistent with healthy ageing; a higher score indicates accelerated inflammatory ageing.

What Shifts It Favourably

The key anti-aging glycan changes — increased galactosylation and sialylation — are produced by regular moderate exercise (the most potent single intervention), weight loss and reduction of visceral adiposity, Mediterranean dietary patterns and adequate dietary fibre, caloric restriction and time-restricted eating, hormonal balance (oestrogen supports galactosyltransferase enzyme activity), and sustained stress reduction. These are precisely the interventions at the core of the Health Absorbed framework.[39,40,41]

Complementary to Epigenetic Clocks

GlycanAge and DunedinPACE measure different dimensions of biological aging and are most powerful when used together. DunedinPACE captures the overall pace of DNA methylation aging across all hallmarks. GlycanAge specifically quantifies the inflammatory glycan arm — Hallmark 13 (inflammaging) — providing a direct readout of the immune system's inflammatory state that is particularly sensitive to the exercise and dietary interventions most relevant to exercise science practitioners.

Key Exercise Evidence — Peer-Reviewed

A study published in Glycoconjugate Journal examined GlycanAge across four groups: professional competing athletes, regularly moderately active individuals, newly recruited recreational exercisers, and inactive controls. Regularly moderately active individuals had a GlycanAge 7.4 years lower than inactive controls — one of the largest single-variable biological age differences recorded in any biomarker study. Critically, professional athletes showed a nominally higher GlycanAge than moderate exercisers (p = 0.032), directly confirming the J-curve relationship between exercise dose and anti-inflammatory benefit: moderate, consistent training optimises IgG glycan composition; extreme training volumes may shift the glycan profile toward pro-inflammation through chronic physiological stress.[39] This finding is uniquely important for exercise practitioners: the prescription that optimises GlycanAge is not the most intense possible programme but the most consistent and sustainable moderate-to-vigorous programme — precisely what Health Absorbed advocates.

Tier 2
Targeted Assessment — Biological Age Characterisation
For individuals with elevated risk profiles, or those seeking deeper biological age measurement beyond standard clinical tests
EPI
CLK
Epigenetic Age Clocks
GrimAge, PhenoAge, DunedinPACE — DNA Methylation Biological Age
Epigenetic clocks predict biological age and mortality risk from DNA methylation patterns at specific CpG sites. GrimAge — trained on time-to-death — is the strongest single predictor of morbidity and mortality. DunedinPACE measures the pace of aging rather than an absolute age — making it the preferred metric for tracking intervention responses over months.[12,13]
HallmarksH3, H1, H2
EvidenceGrade A
Cost£200–400 commercially
Clock comparison
Horvath (2013): 353 CpGs, accurate across tissues, less sensitive to lifestyle variation. PhenoAge (2018): 513 CpGs, trained on clinical phenotypic data, stronger disease and mortality predictor than Horvath. GrimAge (2019): ~1,000 CpGs, trained on time-to-death, currently the strongest predictor — each year of GrimAge acceleration associated with ~10% increased all-cause mortality risk. DunedinPACE: measures pace of aging, most sensitive to intervention over months.
Interpretation and action
GrimAge acceleration ≥2 years above chronological age: comprehensive lifestyle optimisation. ≥5 years: consider pharmacological adjuncts. DunedinPACE >1.0: aging faster than average — intensify lifestyle interventions. DunedinPACE <1.0: aging slower — current programme is working. The CALERIE caloric restriction trial proved that DunedinPACE is measurably modifiable in humans — the first RCT demonstration that biological aging rate is reversible.
Providers
TruDiagnostic (TruAge COMPLETE — includes DunedinPACE and GrimAge), Elysium Health (Index), Chronomics, and Iollo offer validated commercial testing. Blood sample is collected at home or in clinic and posted to the laboratory, with results returned digitally.
Complementary to GlycanAge
Used together, epigenetic clocks (overall biological aging pace) and GlycanAge (inflammatory glycan aging dimension) provide complementary information about different aspects of the biological aging process. An individual may have a favourable DunedinPACE but an elevated GlycanAge — indicating that chronic inflammation is a disproportionate contributor to their aging despite overall good biological age metrics.
TELO
Telomere Length
Replicative Senescence Threshold — DNA Damage Accumulation Marker
Telomere length reflects the cumulative history of cellular replication stress and oxidative DNA damage (Hallmark 2). Critically short telomeres trigger replicative senescence (H9) or apoptosis. Chronic psychological stress accelerates telomere attrition — making telomere length a molecular readout of the intersection of biological and psychosocial aging.[14,15]
HallmarksH2, H9, H16
EvidenceGrade A/B
Cost£150–300 commercially
Measurement methods
qPCR (mean telomere length from white blood cells) — most widely used commercially. FISH (fluorescence in situ hybridisation) — more precise, measures individual chromosome telomere distribution. Southern blot — the research gold standard but impractical clinically. Commercial providers include Life Length (Spain), SpectraCell, and TeloYears.
Limitations
Telomere length explains only 15–25% of the variance in chronological age — substantially less than GlycanAge (58%) or epigenetic clocks. White blood cell telomere length may not accurately reflect telomere length in other tissues. High between-person variability makes single-point measurements less informative than longitudinal tracking. Most useful as a component of a multi-biomarker panel rather than a standalone biological age measure.
Exercise and telomeres
Aerobic exercise is the most robustly evidence-based lifestyle intervention for telomere preservation — reducing the rate of telomere attrition and in some studies increasing telomerase activity. A Mediterranean dietary pattern further supports telomere maintenance. Chronic psychological stress is among the most powerful accelerators of telomere shortening through HPA-axis-mediated oxidative damage to telomeric DNA.
Interpretation
Compare your telomere length percentile for your chronological age cohort. Below the 25th percentile warrants intensified lifestyle optimisation. Above the 75th percentile for your age indicates telomere preservation consistent with slower biological aging. Longitudinal tracking (retesting every 12–18 months) is more informative than single-point measurement for assessing intervention response.
MICRO
Gut Microbiome Analysis
Dysbiosis Assessment — Inflammaging Source Quantification
The gut microbiome undergoes systematic pro-inflammatory compositional changes with aging — reduced diversity, loss of butyrate-producing Firmicutes, and expansion of LPS-producing Proteobacteria. These changes directly fuel inflammaging (H13) through LPS translocation into systemic circulation. Commercially available sequencing provides actionable dietary guidance.[16]
HallmarksH14, H13, H6
EvidenceGrade A/B
Cost£100–250 commercially
Key markers of healthy aging microbiome
High Shannon diversity index (diversity declines with age and illness). Adequate abundance of Faecalibacterium prausnitzii, Roseburia intestinalis, and Akkermansia muciniphila — key butyrate producers and gut barrier protectors. Low ratio of Proteobacteria to Firmicutes. Evidence of adequate fiber fermentation capacity from SCFA producer abundance.
Dietary intervention
The Mediterranean dietary pattern — specifically ≥30g daily dietary fibre from diverse plant sources — is the most evidence-based intervention for microbiome diversity restoration and LPS reduction. Fermented foods (kefir, yogurt, kimchi, sauerkraut) demonstrably increase microbiome diversity and reduce inflammatory markers in RCT evidence. Prebiotic supplementation (inulin, fructo-oligosaccharides) supports beneficial species selectively.
Providers
Viome (combined microbiome and mitochondrial function assessment), Genova Diagnostics GI Effects (most clinically detailed), ZOE (linked to the PREDICT nutrition study), Thryve, and Biomesight. Quality and actionability vary significantly — Genova and ZOE provide the most clinically validated results.
GlycanAge connection
Gut dysbiosis and GlycanAge are biologically linked through the same inflammaging pathway: dysbiotic LPS translocation activates macrophages to produce IL-6 and TNF-α, which promote pro-inflammatory IgG glycan modification. Improving the microbiome and reducing LPS burden is expected to favourably shift GlycanAge — a mechanistic prediction awaiting dedicated study but well-supported by the shared downstream pathway.
Tier 3
Advanced Precision Longevity Assessment
Frontier testing for practitioners and individuals seeking comprehensive multi-hallmark biological age profiling
CHIP
CHIP Panel — Clonal Haematopoiesis
RNA Processing Dysregulation — Cardiovascular and Haematological Risk
Somatic mutations in DNMT3A, TET2, ASXL1, and SF3B1 accumulate in haematopoietic stem cells with age, producing clonal expansion that affects >10% of adults over 70. CHIP mutations — particularly TET2 — drive extreme macrophage pro-inflammatory polarisation, producing atherogenic monocytes that contribute disproportionately to cardiovascular inflammaging (Hallmark 5 and 13).[17]
HallmarksH5, H13, H9
EvidenceGrade A
IndicationElevated CV risk or unexplained anaemia
Clinical significance
CHIP confers a 1.9-fold increase in cardiovascular event risk and a 10-fold increase in haematological malignancy risk. TET2 mutations produce macrophages with constitutively active NLRP3 inflammasome — generating the same amplified inflammatory response that the CANTOS trial targeted with canakinumab. Variant allele frequency (VAF) >2% indicates a substantial clonal burden requiring active cardiovascular risk management.
Management
Detection of CHIP warrants aggressive management of all modifiable cardiovascular risk factors: LDL below 1.8 mmol/L, blood pressure below 120/80 mmHg, smoking cessation, anti-inflammatory lifestyle intensification. Colchicine 0.5 mg daily (now a guideline-recommended anti-inflammatory in cardiovascular risk) may be particularly relevant in CHIP-positive individuals. Haematology referral for VAF >2% and any cytopaenia.
PROT
Plasma Proteomics
Systemic Aging Milieu — Comprehensive Biomarker Profiling
Plasma proteomics platforms (SomaScan 5000, Olink Explore) measure thousands of circulating proteins simultaneously, tracking the three waves of proteomic aging (34, 60, and 78 years) that reflect inflammatory, metabolic, and tissue maintenance biology across multiple hallmarks. GDF15 — an emerging integrated stress and aging biomarker — is of particular clinical interest as it rises exponentially with age and correlates with mortality risk.[18]
HallmarksH12, H13, H9, H11
EvidenceGrade B
AvailabilityResearch/premium commercial
Key aging proteins tracked
Pro-aging (increase with age): GDF15, CCL11 (eotaxin, suppresses neurogenesis), TGF-β1 (fibrosis driver), β2-microglobulin (impairs hippocampal function), MIF (pro-inflammatory). Anti-aging (decrease with age): Klotho (cardiovascular and cognitive protection), TIMP2 (hippocampal function), oxytocin (muscle satellite cell activation). Normalising these trajectories is a central goal of longevity interventions targeting H12.
Clinical availability
SomaScan is available through specialist longevity medicine clinics and some research institutions. Olink Explore is primarily a research platform. GDF15 alone — the single most accessible advanced proteomic marker — is available as an add-on to standard clinical panels and provides substantial prognostic information at low additional cost. Target: GDF15 <1,200 pg/mL.
Integrated Assessment Protocol

The Health Absorbed Biological Age Assessment Protocol

The following protocol integrates the assessment battery above into a practical, evidence-based sequence that can be implemented by any motivated adult — from standard clinical tests through to commercial biological age measurement — with progressive depth based on individual goals and resources.

Phase 1 — Immediate (no cost, this week)Baseline Functional Snapshot
1
Resting heart rate and HRV: Five minutes lying still each morning for seven days using a smartphone HRV app (Elite HRV, HRV4Training, or Polar companion app). Calculate your personal baseline RMSSD. This is your autonomic age baseline.
2
Blood pressure: Three readings on each arm, morning and evening for three days, using a validated home sphygmomanometer. Calculate mean of nine readings per arm. Target below 120/80 mmHg.
3
Grip strength: If you have access to a dynamometer, three maximal efforts per hand. If not, the five-times-sit-to-stand test (time to perform five full sit-to-stand cycles from a standard chair without using arms) provides an accessible surrogate — under 12 seconds for adults under 70 indicates good lower body function.
4
Six-minute walk test: Walk at your maximal comfortable pace for six minutes on a measured course. Record distance. Above 450 metres for adults aged 65–74 indicates good cardiorespiratory reserve. Below 300 metres indicates clinical impairment warranting medical assessment.
Phase 2 — Standard Clinical (GP appointment or private lab)Metabolic and Inflammatory Baseline
1
Fasting blood panel: Glucose, HbA1c, fasting insulin (if available), hsCRP, lipid panel (total, HDL, LDL, triglycerides), full blood count, liver and kidney function, vitamin D (25-OH-D), thyroid function (TSH, free T4). This is the foundational inflammaging and metabolic panel assessing Hallmarks 7, 13, and 14.
2
Resting ECG: For all adults over 45 with cardiovascular risk factors. Screens for arrhythmia, conduction abnormalities, and prior silent myocardial infarction before commencing vigorous exercise programmes.
3
VO₂max estimation: If direct CPET is unavailable, the Rockport Walk Test (time to walk one mile at maximum pace, record finishing HR, enter into validated equation) provides an estimate accurate to ±10–15% of direct measurement. Compare your result to age-sex normative values from ACSM guidelines.
Phase 3 — Commercial Biological Age TestingGlycan and Epigenetic Age
1
GlycanAge test: Finger-prick home collection kit, posted to laboratory. Results within 2–3 weeks. Directly measures the inflammatory glycan dimension of biological aging (Hallmark 13). Most useful as a monitoring tool re-tested at 6–12 month intervals following dietary or exercise intervention. Available at glycanage.com.
2
Epigenetic age (DunedinPACE and GrimAge): Blood spot or venous blood sample, posted to laboratory. TruDiagnostic TruAge COMPLETE provides both clocks plus additional biological age markers. Most informative as a tracking tool: baseline reading, then re-test after 12 months of consistent lifestyle intervention.
3
Microbiome analysis (optional): Stool sample collection kit, posted to laboratory. Most useful if inflammatory markers are elevated or gastrointestinal symptoms suggest dysbiosis. Genova GI Effects or ZOE recommended for clinical relevance of results.
Biomarker Comparison

Biological Age Tests — At a Glance

Test What It Measures Hallmarks Sensitivity to Lifestyle Cost Best For
VO₂max Mitochondrial and cardiovascular capacity H7, H8, H12 Very high — months to change Free (estimate) to £150 (CPET) Overall fitness and mortality risk
HRV (RMSSD) Autonomic balance, allostatic load H10, H8, H13 Very high — days to weeks Free — wearable device Daily recovery and training guidance
Grip strength Musculoskeletal reserve, sarcopaenia H11, H9, H8 High — 8–12 weeks Free–£50 (dynamometer) Functional age and mortality prediction
hsCRP / IL-6 Systemic inflammaging level H13, H14, H9 High — weeks to months £20–80 (blood panel) Inflammaging severity and response
GlycanAge IgG glycan inflammatory profile H13, H15, H9 High — months; directly modifiable by exercise and diet £150–250 Inflammaging specifically; exercise and diet response monitoring
DunedinPACE Pace of overall biological aging H3, H1, H2 Moderate — 12–24 months £250–400 Overall biological aging rate and intervention response
GrimAge Time-to-death biological age predictor H3, H1, H2 Moderate — 12–24 months £250–400 Mortality risk stratification and accelerated aging detection
Telomere length Replicative history and senescence threshold H2, H9, H16 Low-moderate — years £150–300 Long-term tracking; stress and oxidative damage history
PWV Arterial stiffness — ECM aging H15, H13 Moderate — months of exercise £50–200 (specialist clinic) Vascular age and cardiovascular risk stratification
Epigenetic microbiome Gut dysbiosis and LPS burden H14, H13, H6 High — weeks to months £100–250 Dietary optimisation and inflammaging source identification
CHIP panel Somatic mutation clonal expansion H5, H13 Low — not directly modifiable £300–600 Cardiovascular risk stratification in high-risk individuals
The Optimal Starting Point for Most Adults

For a motivated adult over 50 beginning a comprehensive biological age assessment, the most informative and cost-effective combination is: (1) baseline hsCRP from a standard blood panel — free via GP; (2) a GlycanAge test — approximately £180, directly measures inflammaging, highly responsive to the exercise and dietary interventions you are likely to implement; (3) VO₂max estimation — free using the Rockport Walk Test. These three tests together assess three distinct dimensions of biological aging across seven hallmarks, cost less than £250 in total, and can all be repeated at 12 months to track intervention response. Add DunedinPACE if you want the broadest biological age readout; add epigenetic microbiome analysis if inflammatory markers are elevated despite lifestyle optimisation.